English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The new GenoType MTBDRsl assay (Hain Lifescience) detects mutations most  frequently associated with resistance to fluoroquinolones (FLQ),  aminoglycosides/cyclic peptides (AG/CP), and ethambutol (EMB) and thus,  enables rapid identification of extensively drug-resistant (XDR)  Mycobacterium tuberculosis strains. A set of 19 multidrug-resistant (MDR)  strains isolated in Serbia in 2011 was tested by the MTBDRsl assay and by  conventional drug susceptibility testing (DST). The sensitivity and  specificity of the MTBDRsl assay were as follows: 100% for both for FLQ; 100%  for both for AG/ CP; and 58.3% and 85.7%, respectively, for EMB. The  sensitivity for detection of XDR strains was 100%. Mutations in the gyrA,  rrs, and embB genes established in local M. tuberculosis strains resistant to  the respective drugs have been reported as the most prevalent in other  studies as well. We recommend the MTBDRsl assay as a screening test for the  preliminary detection of XDR-TB cases in Serbia, but not as a replacement of  the conventional second-line DST. [Projekat Ministarstva nauke Republike  Srbije, br. 175039

Detection of drug-resistant mycobacterium tuberculosis strains isolated in Serbia by the GenoType MTBDRsl assay